• e - ISSN No : 2832-4277
IJRTTE Logo

INTERNATIONAL JOURNAL OF RECENT TRENDS IN TECHNOLOGY AND ENGINEERING (IJRTTE)

AI-Enabled Cloud Bio-Simulation Environments

R Gayathiri
Assistant Professor, Department of Electrical and Electronics Engineering, J.J. College of Engineering , India.
Gajalakshmi S
Department of EEE, New Prince Shri Bhavani College of Engineering and Technology , India.
N Manonmani
Professor, Department of EEE, Sri Krishna College of Engineering and Technology, India.

Keywords: Bio-Simulation, Cloud Computing, Artificial Intelligence, Reinforcement Learning, Multi-Omics Data Processing.

Abstract

It is becoming common that biological research is based on large-scale computational modeling, multi-omics integration, and high-fidelity simulation to comprehend complex molecular and cellular behaviors. Nonetheless, the conventional cloud systems are not configured to support the dynamism and data-intensive nature of the contemporary bio-simulation workloads. In this paper, we are going to introduce an AI-powered Cloud Bio-Simulation Environment (AICBSE), which combines deep learning surrogate models, reinforcement learning-based resource optimization, containerized microservices, and real-time feedback systems into one cloud-native system. The system facilitates the sustained ingestion and processing of genomic, proteomic, metabolomic, and imaging data, which can support adaptive simulation infective programs that reduces parameters in response to the biological responses. The experimental findings show that there is a great advancement in the speed of simulation, biological fidelity, and cloud resource efficiency with the architecture exhibiting quick proliferation among dispersed nodes with low latency and high throughput. Digital twins can be created in real-time, interactive models can be created and experiments conducted with a high throughput due to the integration of AI prediction models and dynamic cloud orchestration. On the whole, the suggested environment offers a paradigm shift with respect to speeding up the process of biological discovery, improving predictive modelling, and assisting next-generation applications in the drug development, personalized medicine and in silico research.
Download Certificate
Details

References

  1. Agapito, G., & Cannataro, M. (2023). An overview on the challenges and limitations using cloud computing in healthcare corporations. Big Data and Cognitive Computing, 7(2), 68. https://doi.org/10.3390/bdcc7020068
  2. Calabrese, B., & Cannataro, M. (2015, February). Cloud computing in healthcare and biomedicine. Scalable Computing: Practice and Experience, 16(1). https://doi.org/10.12694/scpe.v16i1.1057
  3. Tan, Q. W., Goh, W., & Mutwil, M. (2020). LSTrAP-Cloud: A user-friendly cloud computing pipeline to infer coexpression networks. Genes, 11(4), 428. https://doi.org/10.3390/genes11040428
  4. Nelson, T. M., Ghosh, S., & Postler, T. S. (2022). L-RAPiT: A cloud-based computing pipeline for the analysis of long-read RNA sequencing data. International Journal of Molecular Sciences, 23(24), 15851. https://doi.org/10.3390/ijms232415851
  5. Ko, G., Kim, P.-G., Yoon, B.-H., Kim, J., Song, W., Byeon, I., Yoon, J., Lee, B., & Kim, Y.-K. (2024, November). Closha 2.0: A bio-workflow design system for massive genome data analysis on high performance cluster infrastructure. BMC Bioinformatics, 25, 59. https://doi.org/10.1186/s12859-024-05963-8
  6. Li, W., Zhang, Z., Xie, B., He, Y., He, K., Qiu, H., Lu, Z., Jiang, C., Pan, X., He, Y., Hu, W., Liu, W., Que, T., & Hu, Y. (2024). HiOmics: A cloud-based one-stop platform for the comprehensive analysis of large-scale omics data. Computational and Structural Biotechnology Journal, 23, 659–668. https://doi.org/10.1016/j.csbj.2024.01.002
  7. Hu, X., Mar, D., Suzuki, N., & others. (2023). Mass-Suite: A novel open-source Python package for high-resolution mass spectrometry data analysis. Journal of Cheminformatics, 15, 87. https://doi.org/10.1186/s13321-023-00741-9
  8. Swanson, K., Walther, P., Leitz, J., Mukherjee, S., Wu, J. C., Shivnaraine, R. V., & Zou, J. (2024). ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries. Bioinformatics, 40(7), btae416. https://doi.org/10.1093/bioinformatics/btae416
  9. DiNuzzo, M. (2022). How artificial intelligence enables modeling and simulation of biological networks to accelerate drug discovery. Frontiers in Drug Discovery, 2, 1019706. https://doi.org/10.3389/fddsv.2022.1019706
  10. Gervas-Arruga, J., Barba-Romero, M. Á., Fernández-Martín, J. J., Gómez-Cerezo, J. F., Segú-Vergés, C., Ronzoni, G., & Cebolla, J. J. (2024). In silico modeling of Fabry disease pathophysiology for the identification of early cellular damage biomarker candidates. International Journal of Molecular Sciences, 25(19), 10329. https://doi.org/10.3390/ijms251910329
  11. Sack, K. L., Davies, N. H., Guccione, J. M., & Franz, T. (2016). Personalised computational cardiology: Patient-specific modelling in cardiac mechanics and biomaterial injection therapies for myocardial infarction. Heart Failure Reviews, 21(6), 815–826. https://doi.org/10.1007/s10741-016-9528-9
  12. Durán-Iturbide, N. A., Díaz-Eufracio, B. I., & Medina-Franco, J. L. (2020). In silico ADME/Tox profiling of natural products: A focus on BIOFACQUIM. ACS Omega, 5(26), 16076–16084. https://doi.org/10.1021/acsomega.0c01581
  13. Schaduangrat, N., Lampa, S., Simeon, S., & others. (2020). Towards reproducible computational drug discovery. Journal of Cheminformatics, 12, 9. https://doi.org/10.1186/s13321-020-0408-x
  14. Katsoulakis, E., Wang, Q., Wu, H., & others. (2024). Digital twins for health: A scoping review. NPJ Digital Medicine, 7, 77. https://doi.org/10.1038/s41746-024-01073-0
  15. Wang, M., Hu, H., & Wu, S. (2023). Opportunities and challenges of digital twin technology in healthcare. Chinese Medical Journal, 136(23), 2895–2896. https://doi.org/10.1097/CM9.0000000000002896
  16. Elgammal, Z., Albrijawi, M. T., & Alhajj, R. (2025). Digital twins in healthcare: A review of AI-powered practical applications across health domains. Journal of Big Data, 12, 234. https://doi.org/10.1186/s40537-025-01280-w
  17. Saratkar, S. Y., Langote, M., Kumar, P., Gote, P., Weerarathna, I. N., & Mishra, G. V. (2025). Digital twin for personalized medicine development. Frontiers in Digital Health, 7, 1583466. https://doi.org/10.3389/fdgth.2025.1583466
  18. Simalatsar, A. (2023). Synthetic biomedical data generation in support of in silico clinical trials. Frontiers in Big Data, 6, 1085571. https://doi.org/10.3389/fdata.2023.1085571
  19. Leo, C. G., Tumolo, M. R., Sabina, S., Colella, R., Recchia, V., Ponzini, G., Fotiadis, D. I., Bodini, A., & Mincarone, P. (2022). Health technology assessment for in silico medicine: Social, ethical and legal aspects. International Journal of Environmental Research and Public Health, 19(3), 1510. https://doi.org/10.3390/ijerph19031510
  20. Bhardwaj, A., Kishore, S., & Pandey, D. K. (2022). Artificial intelligence in biological sciences. Life, 12(9), 1430. https://doi.org/10.3390/life12091430
  21. Glicksberg, B. S., & Klang, E. (2024). Unveiling recent trends in biomedical artificial intelligence research: Analysis of top-cited papers. Applied Sciences, 14(2), 785. https://doi.org/10.3390/app14020785
  22. Goshisht, M. (2024). Machine learning and deep learning in synthetic biology: Key architectures, applications, and challenges. ACS Omega, 9(2). https://doi.org/10.1021/acsomega.3c05913
  23. Chakraborty, S., Sharma, G., Karmakar, S., & Banerjee, S. (2024). Multi-omics approaches in cancer biology: New era in cancer therapy. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, 1870(5), 167120. https://doi.org/10.1016/j.bbadis.2024.167120
  24. Dhudum, R., Ganeshpurkar, A., & Pawar, A. (2024). Revolutionizing drug discovery: A comprehensive review of AI applications. Drugs and Drug Candidates, 3(1), 148–171. https://doi.org/10.3390/ddc3010009
  25. Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023). The role of AI in drug discovery: Challenges, opportunities, and strategies. Pharmaceuticals, 16(6), 891. https://doi.org/10.3390/ph16060891